Premium
Cariprazine more effective than risperidone for negative symptoms of schizophrenia
Publication year - 2017
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30236
Subject(s) - risperidone , schizophrenia (object oriented programming) , negative symptom , psychiatry , medicine , psychology , antipsychotic drug , antipsychotic , psychotherapist , clinical psychology , psychosis
In what is believed to be the first large‐scale study demonstrating improvement in negative symptoms of schizophrenia from an antipsychotic monotherapy, patients receiving cariprazine over 26 weeks saw greater improvement than patients receiving risperidone. Given the lack of treatment options for schizophrenia patients with predominantly negative symptoms, the findings of this study could carry significant implications for clinical practice, the researchers stated.